TRB-061

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameTRB-061
Drug Alias NameTRB-061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B agonistsT lymphocytes modulators
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsDermatitisDermatitis, AtopicColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrex Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrex Bio Inc
Inactive CompaniesN/A
Active IndicationsDermatitisDermatitis, AtopicColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A